ISIN | LU1585228700 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Bellevue Emerging Markets Healthcare B CHF |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
Distributor(s) |
Bank am Bellevue AG Küsnacht Phone: +41 44 267 67 67 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund is an equity fund. The investment objective of sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the fund in a portfolio of carefully chosen shares and other equity securities of companies that have their registered office or carry out the majority of their economic activity in the healthcare markets of emerging countries. |
Peculiarities |
Current Price * | 104.88 CHF | 30.10.2024 |
---|---|---|
Previous Price * | 107.66 CHF | 29.10.2024 |
52 Week High * | 122.19 CHF | 08.11.2023 |
52 Week Low * | 97.41 CHF | 05.08.2024 |
NAV * | 104.88 CHF | 30.10.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 76,617,010 | |
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | -4.97% |
29.12.2023 - 30.10.2024
29.12.2023 30.10.2024 |
---|---|---|
1 month | -5.51% |
30.09.2024 - 30.10.2024
30.09.2024 30.10.2024 |
3 months | +1.71% |
30.07.2024 - 30.10.2024
30.07.2024 30.10.2024 |
6 months | +0.02% |
30.04.2024 - 30.10.2024
30.04.2024 30.10.2024 |
1 year | -11.10% |
30.10.2023 - 30.10.2024
30.10.2023 30.10.2024 |
2 years | -16.05% |
31.10.2022 - 30.10.2024
31.10.2022 30.10.2024 |
3 years | -41.72% |
02.11.2021 - 30.10.2024
02.11.2021 30.10.2024 |
5 years | -52.44% |
15.06.2021 - 30.10.2024
15.06.2021 30.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Celltrion Inc | 8.02% | |
---|---|---|
Sun Pharmaceuticals Industries Ltd | 6.12% | |
Innovent Biologics Inc | 6.07% | |
Samsung BioLogics Co Ltd | 5.34% | |
Legend Biotech Corp ADR | 4.47% | |
BeiGene Ltd ADR | 4.26% | |
Cipla Ltd | 4.05% | |
Bangkok Dusit Medical Services PCL | 3.41% | |
Apollo Hospitals Enterprise Ltd | 3.39% | |
Chemical Works of Gedeon Richter PLC | 2.85% | |
Last data update | 31.08.2024 |
TER | 2.29% |
---|---|
TER date | 29.01.2021 |
Performance Fee *** | 10.00% |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 2.25% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |